Innovacon

Innovacon is a leading developer and manufacturer of rapid diagnostic tests, specializing in lateral flow immunoassay technology. The company provides a wide range of point-of-care testing solutions across several categories, including toxicology (drugs of abuse), infectious diseases, women's health, and oncology. Originally a part of ACON Laboratories, Innovacon was acquired by Inverness Medical Innovations (now Abbott) in 2006. Its products are used globally by healthcare professionals and in clinical laboratories to provide quick and accurate diagnostic results. The company maintains a strong focus on quality and innovation within the rapid diagnostics market, operating as a key subsidiary within Abbott's diagnostics portfolio.